methylprednisolone has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 91 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (10.99) | 18.7374 |
| 1990's | 41 (45.05) | 18.2507 |
| 2000's | 33 (36.26) | 29.6817 |
| 2010's | 6 (6.59) | 24.3611 |
| 2020's | 1 (1.10) | 2.80 |
| Authors | Studies |
|---|---|
| Akashi, K; Egashira, N; Hosohata, K; Ieiri, I; Ishida, S; Kato, K; Kawashiri, T; Miyamoto, T; Morikawa, H; Murata, S; Nakamura, T; Suetsugu, K; Tsuji, T; Uchida, M; Watanabe, H; Yonemitsu, H | 1 |
| Anwer, F; Guillén-Rodríguez, JM; Heard, K; Inclán, L; Mahadevan, D; Persky, DO; Puvvada, SD; Rivera, XI; Schatz, JH; Yan, J | 1 |
| Al-Darraji, AF; Al-Hadad, S; Al-Jadiry, MF; Foà, R; Mohamed, S; Moleti, ML; Piciocchi, A; Shateh, WA; Testi, AM; Uccini, S | 1 |
| Kato, K | 1 |
| Chen, FY; Huang, HH; Pang, YY; Shao, X; Wang, T; Wu, YL; Xiao, F; Zhong, H; Zhong, JH | 1 |
| Ardeshna, K; Halsey, R; Kayani, I; Skoura, E; Wan, S | 1 |
| Bai, LY; Chang, MS; Chao, SC; Chen, CC; Lin, JS; Liu, JH | 1 |
| Eom, HS; Kang, HJ; Kim, HY; Kim, SJ; Kim, WS; Lee, DH; Nam, SH; Suh, C; Sym, SJ | 1 |
| Bergamaschi, G; Corazza, GR; Girino, M; Gobbi, PG; Lambelet, P; Perfetti, V; Valentino, F | 1 |
| Nishigori, K; Yamamoto, T; Yokozeki, H | 1 |
| Cheng, AL; Kuo, SH; Lin, ZZ; Yang, SH | 1 |
| Beauloye, V; Benmiloud, S; Brichard, B; de Wandeleer, A; Devogelaer, JP; Maiter, D; Steffens, M; Vermylen, C | 1 |
| de Magalhaes-Silverman, M; Gingrich, RD; Hayashi, M; Hohl, RJ; Lee, CK; Schlueter, A; Strauss, RG | 1 |
| Fukuno, K; Goto, H; Hara, T; Kanemura, N; Kasahara, S; Moriwaki, H; Oyama, M; Sawada, M; Shimizu, M; Takami, T; Tsurumi, H; Yamada, T; Yoshikawa, T | 1 |
| Bonelli, RM; Kenner, L; Melinz, K; Niederwieser, G; Reisecker, F | 1 |
| Altés, A; Escoda, L; Guardia, R; López-Guillermo, A; Martino, R; Montserrat, E; Perea, G; Ribera, JM; Salar, A; Sierra, J | 1 |
| Choi, CW; Kim, BS; Kim, JS; Kim, YH; Paek, CW; Seo, JH; Shin, SW | 1 |
| Ayala, A; Cabanillas, F; Hagemeister, FB; Hess, M; Lee, MS; McLaughlin, P; Preti, A; Rodriguez, MA; Romaguera, J; Sarris, A; Smith, TL; Tsimberidou, AM; Yang, Y; Younes, A | 1 |
| Altundağ, MK; Baltali, E; Barişta, I; Celik, I; Güler, N; Güllü, I; Kansu, E; Kars, A; Ozişik, Y; Oztürk, MA; Tekuzman, G; Türker, A; Yalçin, S | 1 |
| Crump, M; Emmanouilides, C; Flinn, I; Frankel, S; Hackett, J; Lazarus, H; Liang, BC; Lovelace, W; Moore, J; Schenkein, D; Vose, JM | 1 |
| BROWN, EB; BURNINGHAM, RA; HARRINGTON, WJ; KHURI, PD; LESSNER, HE; PUGH, RP; RESTREPO, A; SCHLOSSMAN, SF | 1 |
| Ardashev, VN; Korotkiĭ, AN; Mazurov, VI; Seriakov, AP; Ushakov, II | 1 |
| Bromberg, JE; Haaxma-Reiche, H; Harder, H; Holtel, H; Kluin-Nelemans, HC; Menten, J; Poortmans, P; van den Bent, MJ | 1 |
| Arbion, F; Autret, A; Benboubker, L; Bonnaud, I; Cottier, JP; de Toffol, B; Debiais, S; Destrieux, C; Saudeau, D | 1 |
| Aydin, F; Bektas, O; Kavgaci, H; Ozdemir, F; Yavuz, AA; Yavuz, MN; Yilmaz, M | 1 |
| Chi, HS; Huh, J; Kang, YK; Kim, EK; Kim, MW; Kim, S; Kim, SB; Kim, SH; Kim, SW; Lee, J; Lee, JL; Park, CJ; Suh, C | 1 |
| Bartolozzi, F; Chiusolo, P; Laurenti, L; Leone, G; Marra, R; Piccirillo, N; Sica, S; Sorá, F | 1 |
| Adachi, T; Hayashi, M; Hirashima, K; Ichihashi, R; Inukai, A; Ito, M; Katsumi, A; Kojima, T; Matsushita, T; Murata, M; Naoe, T; Nishida, T; Saito, H; Yokozawa, T | 1 |
| Bunworasate, U; Intragumtornchai, T; Nakorn, TN; Rojnuckarin, P | 1 |
| Huh, J; Jeong, YP; Kim, S; Kim, SB; Kim, SW; Ko, OB; Koo, JE; Lee, D; Lee, JL; Park, SH; Suh, C | 1 |
| Aydin, S; Dührsen, U; Nückel, H | 1 |
| Bakshi, A; Gujral, S; Gupta, S; Nair, R; Parikh, P; Prabhash, K; Sengar, M | 1 |
| Ardolino, G; Nobile-Orazio, E; Terenghi, F | 1 |
| Blondet, C; Cimarelli, S; Constantinesco, A; Fohrer, C; Herbrecht, R; Imperiale, A | 1 |
| Huang, XJ; Jiang, B; Jiang, Q; Lu, BB; Wang, DB; Yang, SM | 1 |
| Hoover, EA; Olsen, RG; Quackenbush, SL; Rojko, JL | 1 |
| Cabanillas, F; Hagemeister, FB; Lee, MS; McLaughlin, P; Pate, O; Rodriguez, MA; Romaguera, J; Sarris, A; Swan, F; Younes, A | 1 |
| Bastion, Y; Baumelou, E; Bouabdallah, K; Delannoy, A; Dupriez, B; Haioun, C; Herbrecht, R; Morel, P; Nouvel, C; Tilly, H | 1 |
| Angus, B; Carey, P; Evans, RG; Jackson, GH; Lennard, AL; Lucraft, H; Proctor, SJ; Taylor, PR | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Nambo, MJ; Talavera, A | 1 |
| Amill, B; Brunet, S; Domingo-Albós, A; García-López, J; Madoz, P; Martínez, C; Mateu, R; Portos, JM; Subirà, M; Sureda, A | 1 |
| Isoda, K; Kato, H; Matsumura, O; Mitarai, T; Niimi, Y; Tamura, H | 1 |
| Biron, P; Blay, JY; Bouffet, E; Bouhour, D; Brunat-Mentigny, M; Carrie, C; Philip, T | 1 |
| Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W | 1 |
| Bosly, A; Coiffier, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Morel, P; Reyes, F; Sebban, C; Tilly, H | 1 |
| Jacobs, P; Johnson, C; King, HS; Novitzky, N | 1 |
| Dorr, RT | 1 |
| Aul, C; Borchard, F; Hadding, U; Heyll, A; Leschke, M; Meckenstock, G; Mödder, U; Schneider, W; Söhngen, D | 1 |
| Dorr, RT; Lauper, D | 1 |
| Finogenova, IA; Kruglova, GV; Poddubnaia, IV | 1 |
| Johnson, PW; Sweetenham, JW | 1 |
| Abdel-Warith, A; Berry, J; Ezzat, AA; Khalifa, F; Khan, B; Raja, MA | 1 |
| Ebina, K; Kowada, M; Mineura, K; Sasajima, T; Sawataishi, J; Sugawara, A | 1 |
| Bapat, A; Goldberg, J; Goldman, N; Gordon, R; Gryn, J | 1 |
| Bodenstein, H; Dietzfelbinger, H; Eimermacher, H; Engert, A; Freund, M; Herrmann, R; Hiddemann, W; Kreuser, ED; Landys, K; Nahler, M; Neubauer, A; Parwaresch, R; Reuss-Borst, M; Stauder, R; Stein, H; Tiemann, M; Tirier, C; Trümper, L; Unterhalt, M | 1 |
| Fahlenkamp, D; Kirchner, S; Lindeke, A; Loening, SA; Reinke, P; Schnorr, D | 1 |
| Niitsu, N; Umeda, M | 1 |
| Ben Othman, T; Binet, JL; Fardeau, C; Gerber, S; Leblond, V; Lehoang, P; Merle-Béral, H; Reux, I; Soussain, C; Sutton, L | 1 |
| Rodriguez, MA | 1 |
| Amigo, ML; Caballero, MD; del Cañizo, C; García, R; Gonzalez, M; Hernández, JM; San Miguel, JF; Vazquez, L | 1 |
| Amiot, L; Caulet-Maugendre, S; Diebold, J; Drénou, B; Fardel, O; Fauchet, R; Lamy, T; Le Prisé, PY; Sasportes, M | 1 |
| Lundberg, LG; Samuelsson, J | 1 |
| O'Meara, Y; Obrador, GT; Price, B; Salant, DJ | 1 |
| Angus, B; Cameron, DA; Cook, MK; Dawes, PJ; Dawson, AA; Evans, RG; Galloway, MJ; Harris, AL; Heppleston, A; Horne, CH; Krajewski, AS; Lennard, AL; Leonard, RC; Lessells, AM; Lucraft, HH; MacGillivray, JB; Mackie, MJ; Parker, AC; Prescott, RJ; Proctor, SJ; Roberts, JT; Taylor, PR; Thompson, WD; White, JM | 1 |
| Hallahan, D; Mundt, AJ; Williams, SF | 1 |
| Cabanillas, F; Rodriguez-Monge, EJ | 1 |
| Alvarez Alvarez, C; García García, S | 1 |
| Bachier, C; Cabanillas, F; Hagemeister, FB; McLaughlin, P; Preti, H; Rodriguez, MA; Romaguera, JE; Sarris, AH; Weber, D; Younes, A | 1 |
| Chen, PM; Chiou, TJ; Fan, FS; Liu, JH; Tung, SL; Wang, WS; Yen, CC | 1 |
| Albin, N; Binet, JL; Boccaccio, C; Charlotte, F; Delort, J; Gabarre, J; Leblond, V; Merle-Béral, H; Souleau, B; Soussain, C; Sutton, L; Zouabi, H | 1 |
| Boqué, C; Cancelas, JA; Garcia, J; Grañena, A; Muñoz, J; Petit, J; Sarrà, J | 1 |
| Baumelou, E; Caubarrere, I; Couderc, LJ; Epardeau, B; Frachon, I; Hermine, O; Stelianides, S; Stern, M | 1 |
| Akimov, MA; Gershanovich, ML | 1 |
| Chabot, F; Delorme, N; Ferry, R; Guerci, O; Lederlin, P; Polu, JM; Renaudier, P; Witz, B; Witz, F | 1 |
| Bollen, P; Bourgain, C; Duville, L; Van Berlaer, G; Vandenplas, Y | 1 |
| Bosly, A; Brice, P; Brière, J; Coiffier, B; Gaulard, P; Gisselbrecht, C; Haioun, C; Lederlin, P; Lepage, E; Morel, P; Nouvel, C; Reyes, F; Salles, G; Sebban, C; Tilly, H | 1 |
| Büyükpamukçu, M; Caglar, K; Güler, E; Kutluk, T; Varan, A | 1 |
| Assawametha, N; Intragumtornchai, T; Numbenjapon, T; O'Charoen, R; Prayoonwiwat, W; Swasdikul, D | 1 |
| Bi, J; Boswell, W; Espina, BM; Levine, AM; Tulpule, A | 1 |
| Castagnola, C; Corso, A; Nascimbene, C; Vitulo, P; Volpini, E; Zappasodi, P | 1 |
| Cabanillas, F | 2 |
| Gross, M; Johnson, D; Joshi, SS; Kaplan, P; Mirvish, SS; Nickols, J; Tong, HY; Weisenburger, DD | 1 |
| Allan, NC; Dawson, AA; Leonard, RC; Lucraft, HH; McGillivray, JB; Parker, AC; Prescott, RJ; Proctor, SJ | 1 |
| Bianconcini, G; Gobbi, F; Mazzali, F; Morini, A | 1 |
| Blackledge, GR; Child, JA; Ellis, IO; Fletcher, J; Jones, EL; Kavanagh, JA; Kelly, KA; O'Brien, CJ; Perren, TJ; Stuart, NS | 1 |
| Halie, MR; Nieweg, HO; van Imhoff, GW | 1 |
| McClelland, RB | 1 |
| Abadi, A; Choi, OS; Hall, TC; Krant, MJ | 1 |
| Lesowitz, SA; Roenigk, HH | 1 |
| Heindl, E | 1 |
7 review(s) available for methylprednisolone and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
[Malignant lymphoma and adult T-cell leukemia-lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Genetic Markers; Genetic Testing; Hodgkin Disease; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Methylprednisolone; Positron-Emission Tomography; Prednisone; Vincristine | 2014 |
[Diffuse alveolar hemorrhage as a complication in patients with hematologic malignancies after chemotherapy: report of two cases and literature review].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hemorrhage; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Alveoli | 2007 |
Primary central nervous system involvement of the so called 'peripheral T-cell lymphoma'. Report of a case and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Basal Ganglia; Biopsy; Brain Neoplasms; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Female; Humans; Immunophenotyping; Life Tables; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Methotrexate; Methylprednisolone; Middle Aged; Survival Analysis; Vincristine | 1993 |
Malignant tumours after renal transplantation.
Topics: Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Postoperative Complications; Prednisolone; Risk | 1996 |
Factors that influence prognosis of intermediate-grade lymphomas at relapse.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Cisplatin; Cytarabine; Etoposide; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Outcome Assessment, Health Care; Prognosis | 1996 |
The emergence of Hodgkin's disease in a patient with long-standing chronic lymphocytic leukemia--case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophosphamide; Disease Progression; Humans; Hydrocortisone; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Vincristine | 1997 |
Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Pulmonary Fibrosis; Retrospective Studies; Vindesine | 1999 |
28 trial(s) available for methylprednisolone and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Remission Induction | 2018 |
A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Survival Rate | 2009 |
Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Disease-Free Survival; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Recurrence; Salvage Therapy; Survival Rate; Time Factors | 2009 |
A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantation.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cytarabine; Drug Resistance, Neoplasm; Drug Tolerance; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Neutropenia; Salvage Therapy | 2002 |
A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Salvage Therapy; Survival Rate; Time Factors; Treatment Failure; Vincristine | 2002 |
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vidarabine; Vincristine | 2002 |
Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis | 2002 |
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Injections, Subcutaneous; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Treatment Outcome | 2003 |
Mitoxantrone, carboplatin, cytosine arabinoside, and methylprednisolone followed by autologous peripheral blood stem cell transplantation: a salvage regimen for patients with refractory or recurrent non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Recurrence; Salvage Therapy; Transplantation, Autologous | 2006 |
Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Proportional Hazards Models; Rituximab; Time Factors; Treatment Outcome; Vincristine | 2006 |
ESHAP salvage therapy for refractory and relapsed non-Hodgkin's lymphoma: a single center experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease Progression; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Salvage Therapy; Survival Analysis; Treatment Failure | 2006 |
Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome | 2007 |
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Neoplasm Staging; Oncogenes; Polymerase Chain Reaction; Prednisone; Procarbazine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Remission Induction; Treatment Outcome; Vincristine | 1994 |
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Creatinine; Cyclophosphamide; Doxorubicin; Female; Humans; Kidney; Kidney Neoplasms; L-Lactate Dehydrogenase; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Proportional Hazards Models; Remission Induction; Survival Analysis; Survival Rate; Treatment Outcome; Vindesine | 1994 |
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Bone Marrow Transplantation; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Prednisolone; Retrospective Studies; Risk Factors; Vincristine; Vindesine | 1994 |
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vincristine | 1994 |
Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Salvage Therapy; Transplantation, Autologous | 1995 |
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; France; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Remission Induction; Survival Rate; Transplantation, Autologous; Vindesine | 1993 |
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednimustine; Remission Induction; Treatment Outcome; Vincristine | 1996 |
Salvage chemotherapy for relapsed or refractory non-Hodgkin's lymphoma with a combination of ACES (high-dose Ara C, carboplatin, etoposide and steroids) therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Survival Analysis | 1996 |
A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Prospective Studies | 1996 |
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Survival Rate; Vincristine; Vindesine | 1997 |
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Paclitaxel; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Treatment Outcome | 1998 |
ESHAP as salvage therapy for refractory non-Hodgkin's lymphoma: Taiwan experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Recurrence; Remission Induction; Salvage Therapy; Survival Analysis | 1999 |
Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Recurrence; Survival Analysis | 1999 |
Feasibility of ESHAP + G-CSF as peripheral blood hematopoietic progenitor cell mobilisation regimen in resistant and relapsed lymphoma: a single-center study of 22 patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Recurrence | 1999 |
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.
Topics: Adult; Age Factors; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Statistics, Nonparametric; Vindesine | 2000 |
CHOP versus CHOP plus ESHAP and high-dose therapy with autologous peripheral blood progenitor cell transplantation for high-intermediate-risk and high-risk aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine | 2000 |
56 other study(ies) available for methylprednisolone and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin's Lymphoma Receiving ESHAP±R Therapy.
Topics: Adult; Cisplatin; Cytarabine; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone | 2022 |
Long-term results with the adapted LMB 96 protocol in children with B-cell non Hodgkin lymphoma treated in Iraq: comparison in two subsequent cohorts of patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Hydrocortisone; Infant; Iraq; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2019 |
Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC.
Topics: Apoptosis; Blotting, Western; Cell Cycle Checkpoints; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Deoxyglucose; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Glucocorticoids; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lymphoma, Non-Hodgkin; Methylprednisolone; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2015 |
False-Positive 18F-FDG PET/CT Imaging: Dramatic "Flare Response" After Rituximab Administration.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed | 2016 |
Predictors for successful mobilization of peripheral blood progenitor cells with ESHAP + G-CSF in patients with pretreated non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cisplatin; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation | 2008 |
Vesiculo-bullous dermatomyositis: report of three cases.
Topics: Anti-Inflammatory Agents; Breast Neoplasms; Dermatomyositis; Fatigue; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Methylprednisolone; Middle Aged; Muscle Weakness; Paraneoplastic Syndromes; Prednisolone; Skin Diseases, Vesiculobullous | 2009 |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Glucocorticoids; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy | 2009 |
Long-term effects on bone mineral density of different therapeutic schemes for acute lymphoblastic leukemia or non-Hodgkin lymphoma during childhood.
Topics: Antineoplastic Agents; Body Height; Bone Density; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cranial Irradiation; Dexamethasone; Female; Femur Neck; Follow-Up Studies; Hip; Humans; Lumbar Vertebrae; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sex Characteristics; Whole-Body Irradiation | 2010 |
[Primary high-grade B-cell lymphoma of the CNS. Case report and review of the literature].
Topics: Aged; Biopsy; Bipolar Disorder; Brain; Brain Neoplasms; Diagnosis, Differential; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Neurologic Examination; Tomography, X-Ray Computed | 2002 |
High-dose infusional ifosfamide, etoposide plus methylprednisolone followed by dexamethasone, high-dose ara-C and cisplatinum and autologous stem cell transplantation for refractory or relapsed aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Recurrence; Salvage Therapy; Stem Cell Transplantation; Time Factors | 2002 |
ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Cytarabine; Disease-Free Survival; Drug Tolerance; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Recurrence; Retrospective Studies; Salvage Therapy | 2002 |
WEEKLY HIGH-DOSAGE GLUCOCORTICOSTEROID TREATMENT OF LYMPHOCYTIC LEUKEMIAS AND LYMPHOMAS.
Topics: Anemia; Anemia, Hemolytic; Betamethasone; Chlorambucil; Dexamethasone; Geriatrics; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mercaptopurine; Methylprednisolone; Pharmacology; Prednisone; Radiotherapy; Thrombocytopenia; Triamcinolone | 1964 |
[Principles of treatment and military medical examination of the patients with indolent Non-Hodgkin's lymphomas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Disability Evaluation; Doxorubicin; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Military Personnel; Neoplasm Staging; Prednisone; Russia; Vincristine | 2003 |
Cognitive status and quality of life after treatment for primary CNS lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Carmustine; Case-Control Studies; Central Nervous System Neoplasms; Cognition Disorders; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Hydrocortisone; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelin Sheath; Neuropsychological Tests; Prospective Studies; Quality of Life; Teniposide | 2004 |
A spinal cord intravascular lymphomatosis with exceptionally good outcome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Carmustine; Central Nervous System; Combined Modality Therapy; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Methylprednisolone; Paraplegia; Spinal Cord Neoplasms; Teniposide | 2004 |
The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Interleukin-10; Interleukin-2; Interleukin-6; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Regression Analysis; Time Factors; Treatment Outcome; Vincristine | 2004 |
ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation, Autologous | 2005 |
High titer of ADAMTS13 inhibitor associated with thrombotic microangiopathy of the gut and skeletal muscle after allogeneic hematopoietic stem cell transplantation.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Anti-Inflammatory Agents; Autoimmune Diseases; Blood Coagulation Factor Inhibitors; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Thrombosis | 2006 |
The effect of short-term intensive chemotherapy on reactivation of tuberculosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Mycobacterium tuberculosis; Prednisone; Retrospective Studies; Tuberculosis; Vincristine; Virus Activation | 2007 |
Guillain-Barré syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Plasma Exchange; Prednisone; Rituximab; Vincristine | 2007 |
[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography for early evaluation of treatment efficacy in advanced non-Hodgkin lymphoma of uterine corpus: a case report.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rituximab; Treatment Outcome; Uterine Neoplasms; Vincristine | 2007 |
Reactivation of latent feline leukaemia virus infection.
Topics: Adrenal Cortex Hormones; Animals; Antibody-Dependent Cell Cytotoxicity; Antigens, Viral; Bone Marrow; Cats; Cells, Cultured; Female; Leukemia Virus, Feline; Leukemia, Experimental; Leukocytes; Lymphoma, Non-Hodgkin; Macrophages; Male; Methylprednisolone; Virus Activation | 1982 |
Late-onset renal dysfunction in a patient with non-Hodgkin's lymphoma following an autologous bone marrow transplantation.
Topics: Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Renal Insufficiency | 1995 |
The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Folic Acid; Humans; Hydrocortisone; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Pilot Projects; Platelet Transfusion; Prognosis; Prospective Studies; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine | 1995 |
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisolone; Prospective Studies; Recurrence; Salvage Therapy; Vincristine | 1995 |
Treatment of aggressive non-Hodgkin's lymphoma in the elderly.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged | 1995 |
Correction to Cancer Therapy Protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone | 1994 |
Possible transmission of sarcoidosis via allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Humans; Liver Diseases; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Sarcoidosis; Transplantation, Homologous | 1994 |
Dosing error in protocol book.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone | 1994 |
[The use of a daily dose of methylprednisolone (Medrol) once in treating hemoblastoses].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Tablets | 1994 |
ESHAP chemotherapy for relapsed/refractory non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone; Prognosis; Recurrence; Survival Rate; Treatment Outcome | 1994 |
E-SHAP: an effective treatment in selected patients with relapsed non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neutropenia; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia | 1994 |
Pentostatin increases the acute toxicity of high dose cyclophosphamide.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Synergism; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Pentostatin; Prednisone; Rats; Rats, Inbred Lew; Salvage Therapy; Shock, Cardiogenic; Ventricular Fibrillation; Vidarabine; Vincristine | 1993 |
Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methylprednisolone; Middle Aged; Myeloproliferative Disorders; Neutropenia; Salvage Therapy; Survival Rate; Time Factors | 1997 |
CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; CD3 Complex; CD56 Antigen; Cell Nucleus; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Femoral Neoplasms; Herpesvirus 4, Human; Humans; Idarubicin; Immunophenotyping; Killer Cells, Natural; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methylprednisolone; Neoplasm Invasiveness; Neoplasm Proteins; Neoplastic Stem Cells; Pelvic Neoplasms; Prednisone; Quinine; Vincristine | 1997 |
Acute renal failure due to lymphomatous infiltration of the kidneys.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Creatinine; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Hematuria; Humans; Kidney; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Ultrasonography; Vincristine | 1997 |
High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: pattern of failure and implications for involved-field radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoguazone; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Treatment Failure | 1997 |
Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone; Methylprednisolone Hemisuccinate; Mitoxantrone; Prognosis; Salvage Therapy; Texas; Treatment Outcome | 1997 |
[Pleural tumor as the only manifestation of lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Pleural Neoplasms; Tomography, X-Ray Computed; Vincristine | 1997 |
[Evaluation of the CCNU-COP regimen for primary refractory and recurrent non-Hodgkin's lymphoma].
Topics: Adult; Aged; Anemia; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Hydrocortisone; Leukopenia; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Treatment Outcome; Vincristine | 1999 |
[Methotrexate pneumonitis arising during the treatment of non-Hodgkin's lymphomas with the m-BACOD protocol].
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Oxygen Inhalation Therapy; Pneumonia; Vincristine | 1995 |
Non-Hodgkin lymphoma presenting as a solitary rectal polyp.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Colonoscopy; Cyclophosphamide; Doxorubicin; Gastrointestinal Hemorrhage; Humans; Hydrocortisone; Immunophenotyping; Intestinal Mucosa; Intestinal Polyps; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Rectum; Vincristine | 2000 |
Management of obstructive jaundice caused by non-hodgkin lymphoma in children.
Topics: Adolescent; Bilirubin; Child; Cholestasis; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone | 2001 |
High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cisplatin; Cytarabine; Dexamethasone; Drug Therapy, Combination; Etoposide; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2001 |
Successful therapy with high-dose steroids and cyclosporine for the treatment of carmustine-mediated lung injury.
Topics: Adult; Antineoplastic Agents, Alkylating; Carmustine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone; Respiratory Distress Syndrome | 2002 |
Non-Hodgkin's lymphomas: a review of the M.D. Anderson experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Salvage Therapy; Texas; Vincristine | 1992 |
Experience with salvage regimens at M.D. Anderson Hospital.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Methylprednisolone; Methylprednisolone Hemisuccinate; Mitoguazone; Mitoxantrone; Remission Induction; Survival Rate | 1991 |
Effects of 2,4,5-trichlorophenoxyacetic acid, pentachlorophenol, methylprednisolone, and Freund's adjuvant on 2-hydroxyethylnitrosourea carcinogenesis in MRC-Wistar rats.
Topics: 2,4,5-Trichlorophenoxyacetic Acid; Animals; Body Weight; Carcinogenicity Tests; Cocarcinogenesis; Ethylnitrosourea; Female; Freund's Adjuvant; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Mice; Nitrosourea Compounds; Pentachlorophenol; Rats; Rats, Inbred Strains | 1991 |
Methylprednisolone, etoposide, vindesine, and chlorambucil (PEEC) alone or alternating with CHOP as initial or salvage therapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Nausea; Prednisone; Prognosis; Remission Induction; Vincristine; Vindesine | 1988 |
[Antiemetic protocol in oncohematologic polychemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chlorpheniramine; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Sulpiride; Vomiting | 1988 |
A new approach to the treatment of advanced high-grade non-Hodgkin's lymphoma--intensive two-phase chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neutropenia; Procarbazine; Vincristine | 1988 |
High-dose methylprednisolone, vincristine, MTX, and ara-C (SOMA) as initial bulk reducing therapy in non-Hodgkin's lymphoma of unfavorable histology: preliminary results of an ongoing phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Vincristine | 1987 |
Chemotherapy in reticulum-cell sarcoma in five dogs and a cat and in mast-cell leukemia in a cat.
Topics: Animals; Antineoplastic Agents; Azirines; Carbamates; Cat Diseases; Cats; Cyclophosphamide; Dog Diseases; Dogs; Facial Neoplasms; Female; Leukemia; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Male; Mast Cells; Methylprednisolone; Neoplasm Recurrence, Local; Skin Neoplasms | 1971 |
High-dose corticoid therapy in Hodgkin's disease and other lymphomas.
Topics: Adolescent; Adult; Aged; Cortisone; Diabetes Mellitus; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Infections; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mental Disorders; Methylprednisolone; Middle Aged; Prednisolone; Prednisone | 1967 |
Lymphocytoma cutis.
Topics: Humans; Hydroxychloroquine; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Skin Neoplasms | 1970 |
[Symptomatic Sjorgren's syndrome following lymphosarcoma].
Topics: Female; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone; Middle Aged; Mouth Mucosa; Parotid Neoplasms; Sjogren's Syndrome | 1967 |